Vericiguat: all 33 studies that test it
Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis ProgressionRecruitingNCT07715279Phase 2
- Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure PatientsNot yet recruitingNCT07697833Phase 4
- Efficacy of Verciguat in TR and RV FailureNot yet recruitingNCT07668739Phase 4
- Perioperative Vericiguat in Patients Undergoing Cardiovascular SurgeryNot yet recruitingNCT07594509Not applicable
- Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG TrialRecruitingNCT07444398Phase 1
- Vericiguat and Reverse Remodeling Indices in Heart FailureRecruitingNCT07405944Phase 4
- A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart FailureRecruitingNCT07047547Not applicable
- Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial InfarctionNot yet recruitingNCT06812546Phase 4
- The CardioMEMS Vericiguat Heart Failure TrialNot yet recruitingNCT06671990Phase 4
- COgnitioN With VERiciGuat Evaluation in Heart FailureRecruitingNCT06601465Phase 2
- VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling PathwayNot yet recruitingNCT06320951Phase 2
- Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)RecruitingNCT06239974Not applicable
- SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac SurgeryRecruitingNCT05812755Phase 4
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)RecruitingNCT05714085Phase 2/3
- A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection FractionCompletedNCT06195930Phase 2Results posted
- Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular DysfunctionCompletedNCT05711719Phase 2Results posted
- The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and InflammationCompletedNCT05420012Phase 4Results posted
- A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)CompletedNCT05093933Phase 3Results posted
- Patient-reported Outcomes in Vericiguat-treated Patients With HFpEFCompletedNCT03547583Phase 2Results posted
- A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)CompletedNCT02861534Phase 3Results posted
- Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)CompletedNCT01951638Phase 2Results posted
- Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)CompletedNCT01951625Phase 2Results posted
- The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina PectorisCompletedNCT06415227Phase 2
- A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac DysfunctionActive, not recruitingNCT05806138Phase 2
- Impact of Vericiguat on Hemodynamics of Heart FailureActive, not recruitingNCT05704478Phase 4
- Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 SyndromeActive, not recruitingNCT05697640Phase 2
- A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)CompletedNCT05658458Phase 4
- A Study in Healthy Adult Male Participants to Learn the Way Vericiguat is Absorbed With and Without Food When Taken as a Single Dose in Liquid Form Suitable for Children Compared to a 10 Milligram (mg) Tablet That Releases the Active Substance ImmediatelyCompletedNCT05086952Phase 1
- A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Liver Disease and in Age-, Weight- and Gender-matched Healthy ParticipantsCompletedNCT04722562Phase 1
- A Trial to Learn How Safe Vericiguat (BAY1021189) is and the Way the Body Absorbs, Distributes and Gets Rid of Vericiguat in Participants With Kidney Disease and in Age-, Weight- and Gender-matched Healthy ParticipantsCompletedNCT04722484Phase 1
- Study to Evaluate the QT / QTc Interval Prolongation Potential of VericiguatCompletedNCT03504982Phase 1
- Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease PatientsCompletedNCT03255512Phase 1
- Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease PatientsCompletedNCT02617550Phase 1